News for Healthier Living

Houston Methodist Develops First Personalized mRNA Cancer Vaccine for Osteosarcoma

In a breakthrough poised to reshape cancer treatment, Houston Methodist has developed the first personalized mRNA cancer vaccine designed to prevent recurrence of osteosarcoma, a rare and aggressive type of bone cancer.

May 13, 2026


May 13 2026

May 12 2026

May 11 2026

May 10 2026

May 8 2026

May 7 2026

May 6 2026

May 5 2026

May 4 2026

May 1 2026

April 30 2026

April 29 2026